Evidence map›Paper›PMID 19948807›Full record

ArticleJournal of bacteriology2010

Genome sequence of the Fleming strain of Micrococcus luteus, a simple free-living actinobacterium.

Michael Young, Vladislav Artsatbanov, Harry R Beller, Govind Chandra, Keith F Chater, Lynn G Dover, Ee-Been Goh, Tamar Kahan, Arseny S Kaprelyants, Nikos Kyrpides and 12 more

Open access · greenAbstract read
In one paragraph

Article in Journal of bacteriology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
–field-weighted citation impact, top 95% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Whole-genome sequencing and annotation ofMicrobiology resource announcements · 2026
    Article
  3. Unveiling the genomic secrets ofFrontiers in genetics · 2026
    Article
  4. Characterization ofJournal of the American Society for Mass Spectrometry · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Micrococcus spp. as a promising source for drug discovery: A review.Journal of industrial microbiology & biotechnology · 2023
    Review
  12. Article
  13. Pathogenetic characterization of aFrontiers in pediatrics · 2023
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 1 institution in 1 country.

Michael YoungInstitute of Biological, Environmental and Rural Sciences, Aberystwyth University, Penglais Campus, Aberystwyth, Ceredigion SY23 3DD, United Kingdom. miy@aber.ac.uk
Vladislav Artsatbanov
Harry R Beller
Govind Chandra
Keith F Chater
Lynn G Dover
Ee-Been Goh
Tamar Kahan
Arseny S Kaprelyants
Nikos Kyrpides
Alla Lapidus
Stephen R Lowry
Athanasios Lykidis
Jacques Mahillon
Victor Markowitz
Konstantinos Mavromatis
Galina V Mukamolova
Aharon Oren
J Stefan Rokem
Margaret C M Smith
Danielle I Young
Charles L Greenblatt
Aberystwyth University · GB

Funding

Biotechnology and Biological Sciences Research Council BB/F003439/1
6 · The paper itself

Abstract

Micrococcus luteus (NCTC2665, "Fleming strain") has one of the smallest genomes of free-living actinobacteria sequenced to date, comprising a single circular chromosome of 2,501,097 bp (G+C content, 73%) predicted to encode 2,403 proteins. The genome shows extensive synteny with that of the closely related organism, Kocuria rhizophila, from which it was taxonomically separated relatively recently. Despite its small size, the genome harbors 73 insertion sequence (IS) elements, almost all of which are closely related to elements found in other actinobacteria. An IS element is inserted into the rrs gene of one of only two rrn operons found in M. luteus. The genome encodes only four sigma factors and 14 response regulators, a finding indicative of adaptation to a rather strict ecological niche (mammalian skin). The high sensitivity of M. luteus to beta-lactam antibiotics may result from the presence of a reduced set of penicillin-binding proteins and the absence of a wblC gene, which plays an important role in the antibiotic resistance in other actinobacteria. Consistent with the restricted range of compounds it can use as a sole source of carbon for energy and growth, M. luteus has a minimal complement of genes concerned with carbohydrate transport and metabolism and its inability to utilize glucose as a sole carbon source may be due to the apparent absence of a gene encoding glucokinase. Uniquely among characterized bacteria, M. luteus appears to be able to metabolize glycogen only via trehalose and to make trehalose only via glycogen. It has very few genes associated with secondary metabolism. In contrast to most other actinobacteria, M. luteus encodes only one resuscitation-promoting factor (Rpf) required for emergence from dormancy, and its complement of other dormancy-related proteins is also much reduced. M. luteus is capable of long-chain alkene biosynthesis, which is of interest for advanced biofuel production; a three-gene cluster essential for this metabolism has been identified in the genome.

Indexed as

ActinobacteriaGene Expression Regulation, BacterialGenome, BacterialMicrococcus luteusModels, Genetic

Identifiers

PMID19948807
PMCPMC2812450
OpenAlexW1517824578

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.